What Additive Orthopaedics does

Additive Orthopaedics (legal entity Additive Orthopaedic Technologies Inc.) is a privately held orthopedic technology company founded in 2006 and headquartered in Brattleboro, Vermont. The company designs and manufactures patient-specific 3D-printed titanium orthopedic implants using Laser Powder Bed Fusion (LPBF) of medical-grade Ti-6Al-4V alloy. Its core product portfolio addresses complex anatomical defects that off-the-shelf implants cannot solve, including Total Talus Replacement for foot and ankle reconstruction, an Acetabular Revision System for severe hip defects, and Segmental Bone Reconstruction spacers for trauma, oncology, and chronic-infection cases. Each implant is engineered from patient CT/MRI data using AI-assisted anatomical segmentation to produce a digital twin, with proprietary lattice geometries (600-800 micron interconnected porosity) designed to match cancellous bone modulus and promote bone in-growth.

The company supplements its physical implant business with three content and service platforms: a Clinical Evidence Hub aggregating multi-centered studies on bone in-growth and longitudinal implant performance, a Regulatory Insight Platform providing guidance on FDA 510(k), De Novo, and PMA pathways, and a Surgeons' Portal for licensed orthopedic practitioners. The company cites 15+ advanced regulatory pathways evaluated, 20+ regulatory pathways evaluated, a 98% evidence-based clinical adoption rate, and 5k+ multi-centered clinical studies coordinated as part of its evidence platform. Additional revenue-adjacent services include clinical research and education offerings and regulatory strategy consulting for medical device companies.

The go-to-market is a direct enterprise field-sales model targeting orthopedic surgeons, healthcare institutions, and medical device companies, with regional North American distribution. Revenue is generated on a quote-based, one-time-per-implant basis for the core products, supplemented by professional services revenue from regulatory and clinical research engagements. Pricing is not publicly disclosed. Total known external funding is $1,000,000 from Asimov Ventures in January 2018, and the company operates with 11-50 employees. The customer base consists of individual surgeons, research institutes, surgical centers, and a small number of medtech firms rather than large hospital system contracts.

Name

Additive Orthopaedics

Legal name

Additive Orthopaedic Technologies Inc.

Website

https://additiveorthopaedics.com

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Additive Orthopaedics is a privately held medical device company that designs and manufactures patient-specific 3D-printed titanium orthopedic implants using Laser Powder Bed Fusion. It serves orthopedic surgeons, hospitals, and medical device companies with custom implants for complex foot, hip, and segmental bone reconstructions.

Ownership category

akta.pro rank

Product category

Orthopedic Implants

NAICS

Surgical Appliance and Supplies Manufacturing (339113)

SIC

Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842)

akta.pro primary industry

3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ)

akta.pro secondary industries

Orthopedic Joint Reconstruction Implants (Hip/Knee/Shoulder/Elbow/Ankle) (HLAHAEAA), Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG)

Keywords

• 3D-printed orthopedic implants
• Patient-specific titanium implants
• Orthopedic reconstruction devices
• Additive manufacturing medical
• Custom orthopedic solutions

Headquarters

HQ city

Little Silver

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Technology or R&D, Supply Chain, Personnel, Operations, Marketing or Sales

Revenue model

1. Patient-Specific 3D-Printed Implants: Custom-engineered titanium implants designed for individual patient anatomy, primarily targeting complex orthopedic reconstructions including talus replacements, acetabular revisions, and segmental bone reconstruction.
2. Clinical Research & Education Services: Educational content, research hub services, and clinical evidence resources supporting informed surgical adoption of next-generation orthopedic technologies.
3. Regulatory Strategy Services: Expert resources and guidance on FDA regulatory pathways including 510(k) submissions, De Novo classifications, and Premarket Approvals (PMA) for medical device companies.

Go-to-market motion1 record

Distribution channels3 records

Marketing channels6 records

Core offering

Additive Orthopaedics designs, engineers, and manufactures patient-specific 3D-printed orthopedic implants using Laser Powder Bed Fusion (LPBF) on medical-grade Ti-6Al-4V titanium alloy, featuring proprietary lattice geometries (600-800 micron porosity) for bone integration. Core offerings include Total Talus Replacement, Acetabular Revision System, and Segmental Bone Reconstruction solutions, complemented by a Clinical Evidence Hub, Regulatory Insight Platform, and a Surgeons' Portal serving healthcare professionals and medical device developers.

Product overview

Additive Orthopaedics operates as an innovation and education platform offering patient-specific 3D-printed titanium orthopedic implants alongside clinical and regulatory service platforms. The core product portfolio centers on 3D-Printed Implants utilizing Laser Powder Bed Fusion (LPBF) technology, which includes specialized applications: Total Talus Replacement for foot and ankle reconstruction, Acetabular Revision System for hip reconstruction, and Segmental Bone Reconstruction for trauma/oncology cases. These are complemented by the Clinical Evidence Hub for multi-centered research and the Regulatory Insight Platform for FDA pathway guidance. The company also maintains a Surgeons' Portal for healthcare professional access to clinical resources.

Differentiator

Problem solved

Functional benefit

Quantifiable outcome

• 98% evidence-based clinical adoption rate
• +3 more outcomes

Named customers7 records

Segments4 records

Ideal customer profiles4 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

AI capability2 records

Feature5 records

Scale indicators6 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• ConforMIS: ConforMIS (now restor3d) specializes in patient-specific knee replacement implants manufactured using 3D printing and imaging-based customization. Directly comparable to Additive Orthopaedics on the patient-specific implant model for joint reconstruction, though focused on knee.
• Materialise: Materialise provides patient-specific 3D-printed medical devices and surgical planning software across orthopedic and CMF applications. Both companies use CT-based digital workflows and LPBF to produce custom titanium implants with lattice/porous structures.
• Onkos Surgical: Onkos Surgical focuses on patient-specific 3D-printed implants for tumor, revision, and complex orthopedic reconstruction—directly overlapping with Additive Orthopaedics' indications. Both target limb salvage, acetabular revisions, and complex reconstructions through custom titanium solutions.
• 4WEB Medical: 4WEB Medical is a direct competitor specializing in 3D-printed orthopedic implants with proprietary lattice structures for spine, foot/ankle, and trauma. Both companies use LPBF titanium printing and lattice-based osseointegration, competing directly for surgeon share in patient-specific and complex orthopedic reconstructions.
• Lima Corporate: Lima Corporate is a leading European orthopedic implant manufacturer with significant 3D-printed and patient-specific product lines (including custom revision hips and extremities). Overlaps with Additive Orthopaedics on patient-specific acetabular revisions and trauma reconstruction.

Emerging players

• Tangible Solutions: Tangible Solutions is a contract manufacturer specializing in medical-grade 3D-printed titanium implants using LPBF technology. Comparable on additive manufacturing process and materials, serving as both an enabler and competitor for orthopedic implant production.
• Medshape: Medshape (now owned by restor3d) develops patient-specific 3D-printed orthopedic devices with focus on extremities and complex reconstruction. A smaller, niche player with overlapping technology and target indications to Additive Orthopaedics.

Broad incumbents

• Smith+Nephew: Smith+Nephew is a global orthopedic leader with growing investment in 3D-printed and patient-specific implants across hip, knee, and extremities. Comparable to Additive Orthopaedics in indication space, but with substantially greater scale and capital resources.
• DePuy Synthes (Johnson & Johnson): DePuy Synthes is a global orthopedic and spinal implant leader with a portfolio including 3D-printed interbody cages (CONDUIT, EIT Cellular Titanium). Comparable to Additive Orthopaedics on lattice-based osseointegration technology but scaled across a much broader spine/trauma offering.
• Stryker: Stryker is a major orthopedic incumbent with 3D-printed products across knee (Tritanium), hip, and trauma. While its broad portfolio covers similar indications, Stryker's mass-market reach and surgeon relationships create competitive pressure on Additive Orthopaedics across primary and complex revision cases.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/10544904

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds3 records

Investors1 record

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Additive Orthopaedics